Every month, Excellis offers free webinars on DSCSA and the healthcare and pharmaceutical industries.

Upcoming Webinar

Tuesday, March 27 @ 2:00PM EST

Register Today

Past Webinars
Miss our webinars or need a refresher? Our Archive lists the latest Webinars.
Click to access our recordings.
For archived webinars, please contact us.

February 27, 2018: DSCSA Update & Learn the 5 key elements to ensure a great solution selection

Purchasing or replacing a Track and Trace DSCSA Technology Solution? Learn the 5 key elements to ensure a great selection in meeting your organization’s needs. Learn About…

  • DSCSA regulation update & timelines for consideration in selecting a technology solution
  • Compliance and operational value – can both be achieved with a technology solution?
  • Key elements in comparing and selecting a technology solution
  • Considerations of pharmacy manufacturers serializing product by 11/2018
  • Advantages for the pharmacy supply chain
  • Why are so many organizations considering changing solution vendors?

View a Copy of the Recording

December 19, 2017: DSCSA Track and Trace: Achieving Compliance and Improved Medication & Patient Safety

  • Key Elements to ensure compliance and improve medication & patient safety
  • Implications and Opportunities of the November 2017 electronic lot traceability date
  • FDA’s 11/27/2017 guidance regarding grandfathering product & implications for healthcare and retail

View a Copy of the Recording

November 7, 2017: OIG & FDA Latest Report and Impacts to Health Systems
OIG and FDA latest report/guidance & Are you prepared for Electronic Lot Traceability November 2017 Deadline Impact

  • What are the implications of Wholesalers exchanging drug product tracing information using a wide variety of transmission modes and formats?
  • Are direct purchase statements accurate with the required information?
  • How is the determination of DSCSA exempt and non-exempt products? How trading partners might resolve/prevent disagreements?
  • 340B pharmacies: What is the latest guidance regarding the exchange of drug product tracing information for sales to 340B-covered entities that use 340B contract pharmacies?

Contact Us for a copy of the recording